Skip to main content
XTL Biopharmaceuticals Ltd. logo

XTL Biopharmaceuticals Ltd. — Investor Relations & Filings

Ticker · XTLB ISIN · IL0010854979 LEI · 529900NDDXEAPTUTXP41 TA Manufacturing
Open in API
Filings indexed 1,223 across all filing types
Latest filing 2008-02-22 Director's Dealing
Country IL Israel
Listing TA XTLB

About XTL Biopharmaceuticals Ltd.

https://www.xtlbio.com

XTL Biopharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the acquisition and development of pharmaceutical products to address unmet clinical needs. The company's primary therapeutic area of interest is autoimmune diseases. Its development pipeline has included proprietary drug candidates for conditions such as Systemic Lupus Erythematosus (SLE).

Recent filings

Filing Released Lang Actions
Director's Dealing 2008
Director's Dealing
2008-02-22 English
Director's Dealing 2008
Director's Dealing
2008-02-19 English
Director's Dealing 2008
Director's Dealing
2008-02-08 English
Regulatory Filings 2008
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing by a foreign private issuer, XTL Biopharmaceuticals Ltd., submitted to the SEC. It announces that the company's CEO will present at the 10th Annual BIO CEO & Investor Conference, providing an overview of the company and its clinical compound. The document is an announcement of an upcoming investor presentation event, not the presentation itself or a detailed financial report. The length is 3326 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, the document fits best under the category of Investor Presentation (IP) announcement, but since it is only announcing the presentation and not providing the presentation content, it is more appropriate to classify it as a Regulatory Filing (RNS) because it does not contain the actual presentation or detailed financial data. Hence, the best classification is Regulatory Filings (RNS).
2008-02-07 English
Other Report or Announcement
Investor Presentation Classification · 95% confidence The document is a press release announcing that the CEO of XTL Biopharmaceuticals will present at the 10th Annual BIO CEO & Investor Conference. It includes details about the presentation topic, date, and webcast information. There is no financial data, no detailed report, no voting results, no regulatory filing, and no mention of any report being attached or published. The content is clearly an investor presentation announcement, focusing on company strategy and product pipeline. Therefore, the document fits the category of Investor Presentation (IP). The document length is short but contains substantive information about the presentation itself, not just an announcement of a report publication, so it is not RPA or RNS.
2008-02-07 Hebrew (modern)
Other Report or Announcement
Regulatory Filings Classification · 95% confidence The document is very short (1707 characters) and explicitly states that an attached file ('BIOCEO2708Final_isa.pdf') contains information about the 'Company’s Chief Executive Officer, is scheduled to present at the 10th Annual BIO CEO & Investor Conference.' This structure—an announcement referencing an attached presentation or material for an investor event—strongly suggests it is an announcement about an upcoming presentation, rather than the presentation itself (IP) or a general regulatory filing (RNS). Since the event is an 'Investor Conference' presentation, the most fitting category is Investor Presentation (IP). However, given the 'MENU VS MEAL' rule, since this is an announcement *about* the presentation being attached/available, it should be classified as a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Given the context of an investor conference presentation being announced, RPA is slightly more specific than the general RNS fallback, but since the content is about an investor presentation, and it's not a standard periodic report, RNS is often used for miscellaneous announcements. Let's re-evaluate the definitions. It announces participation in an investor conference. This is not a standard report publication like an ER or 10-K. It is an announcement of an event where an Investor Presentation (IP) will likely be given. Because the document itself is just the notification and points to the material, RPA (Report Publication Announcement) is the best fit for the notification itself, as it announces the availability/release of information related to the presentation.
2008-02-07 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.